Novel mRNA vaccine plus immunotherapy reduces melanoma relapse in phase 3 trial

Share on Pinterest Moderna and Merck’s mRNA cancer vaccine combo lowered recurrence risk in a high risk melanoma trial. Tatiana Maksimova/Getty Images Different stages of